Micro-Sphere founder and president of the Board, Dr. Michele Müller, said: “Low dose capsule filling is becoming increasingly popular across the market and at present we are the only CDMO in Europe offering this level of capability.
“Harro Höfliger’s powder expertise and technological competence is particularly evident in the Modu-C MS. This investment is an important next step in our expansion plans, allowing us to meet demand for greater capacity and speed up project delivery for our customers.”
Based in Allmersbach, Germany, Harro Höfliger develops and manufactures production and packaging systems and is a valued development partner for many pharmaceutical and medical technology companies.
Marco Laackmann, business unit leader, inhalation at Harro Höfliger added: “The capacitive fill quantity control of the Modu-C MS offers excellent process reliability and is a great choice for Micro-Sphere in line with its continued expansion. We’re delighted to be a part of their exciting future.”
From its GMP, SwissMedic and FDA approved facility near Lugano, Ticino, Micro-Sphere’s expert team supports customers in the US, Europe, New Zealand and Asia with spray drying and capsule filling capabilities for the development and manufacture of both potent and non-potent pharmaceutical products, with a particular focus on inhalable dosage forms.
Leave a Reply